PR Newswire Global Biotech

Press/Media: Public EngagementPopular

Description

MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures... Researchers will use digital measurement devices and software to measure the effects of microdoses of LSD on neuroplasticity markers such as BDNF plasma levels, as well as on various sleep measures, mood, cognitive performance, regulation of emotions, quality of life, and immune system response. The study will be conducted by Dr. Kim Kuypers of Maastricht University, a leading global authority on the use of low dose psychedelics...

Period16 Nov 2021

Media coverage

1

Media coverage

  • TitlePR Newswire Global Biotech
    Degree of recognitionInternational
    Media name/outletPR Newswire Global Biotech
    Media typeWeb
    Country/TerritoryUnited States
    Date16/11/21
    DescriptionMindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures... Researchers will use digital measurement devices and software to measure the effects of microdoses of LSD on neuroplasticity markers such as BDNF plasma levels, as well as on various sleep measures, mood, cognitive performance, regulation of emotions, quality of life, and immune system response. The study will be conducted by Dr. Kim Kuypers of Maastricht University, a leading global authority on the use of low dose psychedelics...
    Producer/AuthorMind Medicine (MindMed) Inc.
    URLhttps://bionj.org/news/pr-newswire-global?rkey=20211116LA76089&filter=16221
    PersonsKim Kuypers

Keywords

  • LSD on neuroplasticity
  • MindMed executive team
  • MindMed trades
  • actual results
  • applicable securities laws
  • clinical trial risks
  • compelling drug development pipeline
  • compliance with laws
  • digital medicine measurement techniques
  • early stage product development